Advertisements


Biotechs With No Drugs in Trial Are Raising Millions in IPOs

Biotech IPOs are on track for a near-record year, with a crop of offerings that are younger, more highly valued—and some say riskier—than any in recent memory......»»

Category: smallbizSource: wsjOct 31st, 2018

War against the superbugs: Mass. biotechs step up to fight antibiotic resistance

In a world where superbugs are overpowering various antibiotic drugs, threatening millions of lives, Massachusetts biotechs are fighting hard to ensure the bugs don't become the industry's kryptonite......»»

Category: topSource: bizjournalsOct 25th, 2018

The Week Ahead In Biotech: Conferences, Clinical Trial Readouts, Earnings And IPOs

Biotech stocks are on track to extend their losses, bucking the positive broader market sentiment. The week saw Achaogen Inc (NASDAQ: AKAO) filing for Chapter 11 bankruptcy and negative clinical readouts .....»»

Category: earningsSource: benzinga16 hr. 54 min. ago

Facebook stored unencrypted Instagram passwords

"Millions" of Instagram users had their passwords stored in unencrypted form on internal servers, Facebook said Thursday, raising its.....»»

Category: topSource: moneycentralApr 19th, 2019

Facebook says it stored "millions" of unencrypted Instagram passwords

"Millions" of Instagram users had their passwords stored in unencrypted form on internal servers, Facebook said Thursday, raising its.....»»

Category: topSource: moneycentralApr 18th, 2019

Why Startups Marketing Prescription Drugs Need to Tread Carefully: Term Sheet for Tuesday, April 16

On deals and dealmakers. TREAD CAREFULLYRo, a direct-to-consumer telehealth business, is raising another rou.....»»

Category: europeSource: fortuneApr 16th, 2019

The Week Ahead In Biotech: Conferences, Clinical Trial Readouts, Earnings And IPOs

Biotech stocks witnessed a slowdown in momentum last week, which was a relatively slow one in terms of news flow. Amgen, Inc. read more.....»»

Category: blogSource: benzingaApr 13th, 2019

Tesla vs. SEC, More IPOs, and What Brothels Can Teach You About Risk Management

Tesla shareholders probably aren’t feeling too much better after this week’s trial update, but at least it wasn’t the worst-case scenario......»»

Category: topSource: foxnewsApr 10th, 2019

As IPO flood recedes, Asia bankers bet on follow-on capital raising

Bankers in Asia are betting on newly-listed companies returning to the markets for fresh capital as last year's flood of initial public offerings (IPOs) slows to a trickle, with 2019 seeing the weakest start in equity sales in three years......»»

Category: topSource: reutersMar 29th, 2019

Exclusive: D.C. restaurant platform raising millions to add new markets, including Baltimore

The startup's mobile and web platform gives people access to low-cost meals from local restaurants......»»

Category: topSource: bizjournalsMar 27th, 2019

Battery start-ups are raising millions in the battle to crush Tesla

Sila Nanotechnologies, QuantumScape and other battery .....»»

Category: topSource: moneycentralMar 17th, 2019

Why a prominent Columbus developer and an NBA All-Star are raising millions for a Hilltop preschool

“It’s going to be safe, something that people will want to be around. Hopefully that will attract more investment to the neighborhood.”.....»»

Category: topSource: bizjournalsMar 15th, 2019

Why Vertex"s Dilemma Makes It the Best Biotech Stock to Buy Now

Excellent clinical trial results are giving Vertex a problem most biotechs wish they had......»»

Category: topSource: foxnewsMar 10th, 2019

The Week Ahead In Biotech: Conferences, PDUFA Dates, Earnings, IPOs

Last week was an event-filled one for the biotech space, with M&A, FDA decisions, clinical trial results and earnings all on offer. read more.....»»

Category: blogSource: benzingaMar 10th, 2019

The Week Ahead In Biotech: Conferences, PDUFA Dates, Earnings, IPOs

Last week was an event-filled one for the biotech space, with M&A, FDA decisions, clinical trial results and&nb.....»»

Category: earningsSource: benzingaMar 10th, 2019

How Adam Lyons, a former CEO, is prepping for a career in TV; Celebrating entrepreneurs is the goal

After raising tens of millions of dollars in venture capital and growing a successful business, Adam Lyons wants to shine the spotlight on other entrepreneurs. Find out how he plans to do it......»»

Category: topSource: bizjournalsMar 10th, 2019

The Week Ahead In Biotech: Conferences, PDUFA Dates, Clinical Trials, Earnings, IPOs

It was an event-filled one for biotech stocks, with the release of a slew of earnings, presentations of clinical trial results an.....»»

Category: earningsSource: benzingaMar 3rd, 2019

Novartis faces shareholder criticism over drug prices at AGM

Novartis's shift into high-tech drugs won praise for giving new options to patients but criticism for prices that may run into the millions of dollars as the Swiss drugmaker faced investors at its annual general meeting on Thursday......»»

Category: topSource: reutersFeb 28th, 2019

Sarepta doubles down on gene therapies after early Limb-Girdle data

As some biotechs struggle to meet the expectations placed upon gene therapies, Sarepta Therapeutics is investing further in the field, announcing a deal to purchase its development partner for $165 million after positive early clinical trial data. .....»»

Category: topSource: bizjournalsFeb 27th, 2019

U.S. IPO Weekly Recap: 2 Billion-Dollar Biotechs Cap A Mixed Week For Biotech IPOs

U.S. IPO Weekly Recap: 2 Billion-Dollar Biotechs Cap A Mixed Week For Biotech IPOs.....»»

Category: topSource: seekingalphaFeb 9th, 2019

Good ol' boys network, meet black girl magic: Black, female entrepreneurs are changing Silicon Valley

For years, black women have been overlooked in tech. Now their startups are raising millions in venture capital and forcing Silicon Valley to pay attent.....»»

Category: topSource: usatodayJan 24th, 2019